Humana Inc.

NYSE:HUM

Medical - Healthcare Plans

Healthcare
$385.71 +0.19%

+$0.70 today

Market cap
$46.32B
Beta
0.77
P/E (TTM)
38.6
EPS (TTM)
$9.39
Dividend yield
0.98%
52W Low $163.11High $380.86

Volume 4.06M

Average 1.72M

HUM Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

Humana Inc.NYSE: HUM

Stock-Based Compensation · Q3 FY2026 · quarter ended Sep 2026

Stock-based compensation declines year over year

Q3 FY2026 stock-based compensation of $67M fell 19.3% year over year, behind the -6.5% change in trailing-twelve-month stock-based compensation. Sequentially, it rose 3.1% from the prior quarter. Over 3 fiscal years it compounded at +3.7% a year.

Context

  • Stock-based compensation amounted to 0.2% of revenue in FY2025, unchanged from a year earlier.
  • Stock-based compensation increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -19.3% toward the trailing-twelve-month pace of -6.5%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
$67M+3.1% QoQ
Last fiscal yearDec 2025
$241M+16.4% YoY
LTMSep 2026
$231M-6.5% YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-19.3%——
1 year+16.4%——
3-year CAGR+3.7%——
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

USD · from the cash flow

Latest · FY2025
241M USD
Year-over-year change
+16.4%
4-year CAGR
+7.6%

Stock-Based Compensation vs competitors

How HUM compares with its peers on the latest reported figures

  • HUM's LTM Sep 2026 stock-based compensation of $231M is the 4th largest of the 9 companies compared; the peer median is $141.5M.
  • Its year-over-year change of -6.5% is the 5th highest of 8, against a peer median of +2.3%.
  • Stock-based compensation amounts to 0.1% of revenue for HUM, versus a peer median of 0.2%.
HUM Competitors Peer median
Stock-Based Compensation for HUM and competitors
Company Period LTM YoY 3-year CAGR% of revenue
UNHUnitedHealth Group IncorporatedLTM Sep 2026$1.02B +3.8%+1.6%0.2%
CVSCVS Health CorporationLTM Jun 2026$316M -40.6%+6.2%0.1%
ELVElevance Health Inc.LTM Sep 2026$240M +10.6%+1.5%0.1%
HUMHumana Inc.LTM Sep 2026$231M -6.5%+3.7%0.1%
CNCCentene CorporationLTM Jun 2026$178M +2.3%-4.5%0.1%
MOHMolina Healthcare, Inc.LTM Sep 2026$105M +133.3%-23.0%0.2%
OSCROscar Health, Inc.LTM Jun 2026$75.19M -27.9%-7.9%0.5%
ALHCAlignment Healthcare, Inc.LTM Mar 2026$58.91M -12.7%-8.8%1.4%
CICigna CorporationLTM Sep 2026$0 ——0.0%
Peer median (excluding HUM) $141.5M+2.3%-4.5%0.2%

Competitors are the stored peer set for HUM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income2.93B2.8B2.49B1.21B1.2B
Depreciation & Amortization713M845M917M968M824M
Deferred Income Tax15M(100M)(167M)(192M)75M
Stock-Based Compensation180M216M175M207M241M
Change in Working Capital(556M)534M81M154M(1.8B)
Accounts Receivables(280M)(54M)(337M)(669M)(570M)
Inventory00(364M)00
Accounts Payables104M975M915M199M(472M)
Other Working Capital(380M)(387M)(133M)624M(755M)
Other Non-Cash Items(1.02B)290M486M615M375M
Operating Cash Flow2.26B4.59B3.98B2.97B921M
Capital Expenditures(1.34B)(1.14B)(1B)(575M)(546M)
Acquisitions (Net)(4.19B)2.36B(233M)(89M)(81M)
Purchases of Investments(7.2B)(6.05B)(7.55B)(8.19B)(6.44B)
Sales of Investments6.14B3.8B5.09B6.36B9.42B
Other Investing Activities26M17M210M(461M)(82M)
Investing Cash Flow(6.56B)(1.01B)(3.49B)(2.95B)2.27B
Debt Repayment3.76B(1.39B)423M218M431M
Common Stock Issued00000
Common Stock Repurchased(79M)(2.1B)(1.57B)(817M)(151M)
Dividends Paid(354M)(392M)(431M)(431M)(430M)
Other Financing Activities(310M)1.97B725M(1.46B)(1.07B)
Financing Cash Flow3.02B(1.91B)(856M)(2.49B)(1.22B)
Effect of Forex Changes00000
Net Change in Cash(1.28B)1.67B(367M)(2.47B)1.98B
Free Cash Flow920M3.45B2.98B2.39B375M

Humana Inc.

NYSE:HUM

Intrinsic Alpha fair value

Locked

Current Price

$385.71

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.